Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07853573) titled 'Effects of TM02(R) Supplementation on Immune Function in Children' on Sept. 26.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Triple (Participant, Investigator, Outcomes Assessor).
Primary Sponsor: Ligno Biotech Sdn. Bhd.
Condition:
Immune Function
Immunity
Intervention:
Dietary Supplement: TM02(R)
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: June 1, 2025
Target Sample Size: 108
Countries of Recruitment:
Malaysia
To know more, visit https://clinicaltrials.gov/study/NCT07853573
D...